These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 27514313)
1. Analysis of clinical and pathological characteristics, treatment methods, survival, and prognosis of uterine papillary serous carcinoma. Solmaz U; Ekin A; Mat E; Gezer C; Dogan A; Biler A; Peker N; Hasdemir PS; Sanci M Tumori; 2016 Dec; 102(6):593-599. PubMed ID: 27514313 [TBL] [Abstract][Full Text] [Related]
2. Optimal cytoreduction, depth of myometrial invasion, and age are independent prognostic factors for survival in women with uterine papillary serous and clear cell carcinomas. Solmaz U; Mat E; Ekin A; Gezer C; Biler A; Peker N; Ayaz D; Sanci M Int J Surg; 2016 Aug; 32():71-7. PubMed ID: 27365052 [TBL] [Abstract][Full Text] [Related]
3. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases. Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230 [TBL] [Abstract][Full Text] [Related]
4. Uterine papillary serous carcinoma: patterns of failure and survival. Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700 [TBL] [Abstract][Full Text] [Related]
5. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers. Vogel TJ; Knickerbocker A; Shah CA; Schiff MA; Isacson C; Garcia RL; Goff BA J Gynecol Oncol; 2015 Jan; 26(1):25-31. PubMed ID: 25376917 [TBL] [Abstract][Full Text] [Related]
6. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235 [TBL] [Abstract][Full Text] [Related]
7. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus. Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927 [TBL] [Abstract][Full Text] [Related]
9. Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study. Huang CY; Tang YH; Chiang YC; Wang KL; Fu HC; Ke YM; Lau HY; Hsu KF; Wu CH; Cheng WF Gynecol Oncol; 2014 May; 133(2):221-8. PubMed ID: 24556064 [TBL] [Abstract][Full Text] [Related]
10. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC). Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222 [TBL] [Abstract][Full Text] [Related]
12. Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study. Kim M; Kwon BS; Chang HK; Lee S; Chang SJ; Choi JY; Park SY; Lee M; Ryu HS; Kim YB J Gynecol Oncol; 2019 May; 30(3):e44. PubMed ID: 30887761 [TBL] [Abstract][Full Text] [Related]
13. Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen. Lee LJ; Demaria R; Berkowitz R; Matulonis U; Viswanathan AN Gynecol Oncol; 2014 Jan; 132(1):65-9. PubMed ID: 24211401 [TBL] [Abstract][Full Text] [Related]
14. Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study. Gadducci A; Cosio S; Landoni F; Maggino T; Zola P; Fuso L; Sartori E Int J Gynecol Cancer; 2012 Oct; 22(8):1355-60. PubMed ID: 22976496 [TBL] [Abstract][Full Text] [Related]
15. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A; Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209 [TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp. Hanley KZ; Fadare O; Fisher KE; Atkins KA; Mosunjac MB Int J Gynecol Pathol; 2016 May; 35(3):249-55. PubMed ID: 26535985 [TBL] [Abstract][Full Text] [Related]
17. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary? Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227 [TBL] [Abstract][Full Text] [Related]
18. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926 [TBL] [Abstract][Full Text] [Related]
19. Uterine papillary serous carcinoma: state of the state. Naumann RW Curr Oncol Rep; 2008 Nov; 10(6):505-11. PubMed ID: 18928665 [TBL] [Abstract][Full Text] [Related]